» Articles » PMID: 21359191

Increased Risk of Fragility Fractures Among HIV Infected Compared to Uninfected Male Veterans

Abstract

Background: HIV infection has been associated with an increased risk of fragility fracture. We explored whether or not this increased risk persisted in HIV infected and uninfected men when controlling for traditional fragility fracture risk factors.

Methodology/principal Findings: Cox regression models were used to assess the association of HIV infection with the risk for incident hip, vertebral, or upper arm fracture in male Veterans enrolled in the Veterans Aging Cohort Study Virtual Cohort (VACS-VC). We calculated adjusted hazard ratios comparing HIV status and controlling for demographics and other established risk factors. The sample consisted of 119,318 men, 33% of whom were HIV infected (34% aged 50 years or older at baseline, and 55% black or Hispanic). Median body mass index (BMI) was lower in HIV infected compared with uninfected men (25 vs. 28 kg/m²; p<0.0001). Unadjusted risk for fracture was higher among HIV infected compared with uninfected men [HR: 1.32 (95% CI: 1.20, 1.47)]. After adjusting for demographics, comorbid disease, smoking and alcohol abuse, HIV infection remained associated with an increased fracture risk [HR: 1.24 (95% CI: 1.11, 1.39)]. However, adjusting for BMI attenuated this association [HR: 1.10 (95% CI: 0.97, 1.25)]. The only HIV-specific factor associated with fragility fracture was current protease inhibitor use [HR: 1.41 (95% CI: 1.16, 1.70)].

Conclusions/significance: HIV infection is associated with fragility fracture risk. This risk is attenuated by BMI.

Citing Articles

Sex differences in epigenetic ageing for older people living with HIV.

Johnston C, Pang A, Siegler E, Thomas C, Burchett C, Crowley M EBioMedicine. 2025; 113:105588.

PMID: 39923742 PMC: 11849644. DOI: 10.1016/j.ebiom.2025.105588.


The Feasibility and Acceptability of a Clinical Pharmacist-delivered Intervention to Reduce Bothersome Health Symptoms from Polypharmacy and Alcohol Use and Communicate Risk among People with HIV: Pilot Study Protocol.

Womack J, Leblanc M, Sager A, Zaets L, Maisto S, Garcia A AIDS Behav. 2024; 29(2):482-496.

PMID: 39465468 DOI: 10.1007/s10461-024-04533-6.


Bone Tissue Changes in Individuals Living with HIV/AIDS: The Importance of a Hierarchical Approach in Investigating Bone Fragility.

Jadzic J, Dragovic G, Lukic R, Obradovic B, Djuric M J Pers Med. 2024; 14(8).

PMID: 39201983 PMC: 11355540. DOI: 10.3390/jpm14080791.


Bone Disease in HIV: Need for Early Diagnosis and Prevention.

Schinas G, Schinas I, Ntampanlis G, Polyzou E, Gogos C, Akinosoglou K Life (Basel). 2024; 14(4).

PMID: 38672792 PMC: 11051575. DOI: 10.3390/life14040522.


Skeletal muscle DNA methylation: Effects of exercise and HIV.

Jankowski C, Konigsberg I, Wilson M, Sun J, Brown T, Julian C Aging Cell. 2023; 23(1):e14025.

PMID: 37920126 PMC: 10776118. DOI: 10.1111/acel.14025.


References
1.
Collins T, Ewing S, Diem S, Taylor B, Orwoll E, Cummings S . Peripheral arterial disease is associated with higher rates of hip bone loss and increased fracture risk in older men. Circulation. 2009; 119(17):2305-12. PMC: 2766264. DOI: 10.1161/CIRCULATIONAHA.108.820993. View

2.
Kitahata M, Gange S, Abraham A, Merriman B, Saag M, Justice A . Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009; 360(18):1815-26. PMC: 2854555. DOI: 10.1056/NEJMoa0807252. View

3.
Amiel C, Ostertag A, Slama L, Baudoin C, Nguyen T, Lajeunie E . BMD is reduced in HIV-infected men irrespective of treatment. J Bone Miner Res. 2004; 19(3):402-9. DOI: 10.1359/JBMR.0301246. View

4.
Weber R, Sabin C, Friis-Moller N, Reiss P, El-Sadr W, Kirk O . Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006; 166(15):1632-41. DOI: 10.1001/archinte.166.15.1632. View

5.
Bolland M, Grey A, Gamble G, Reid I . CLINICAL Review # : low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis. J Clin Endocrinol Metab. 2007; 92(12):4522-8. DOI: 10.1210/jc.2007-1660. View